Financials in USD. Standardized financial statements.
A compact view of how Biomerica, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $5.31M | $5.42M | $5.34M | $18.87M | $7.20M | $6.69M | $5.20M | $5.56M | $5.79M | $5.14M |
| Revenue Growth? | -1.9% | +1.4% | -71.7% | +162.1% | +7.6% | +28.7% | -6.5% | -3.9% | +12.7% | 0.0% |
| Cost of Revenue? | $4.81M | $4.80M | $4.89M | $15.89M | $6.83M | $4.91M | $3.91M | $3.81M | $3.77M | $3.62M |
| Gross Profit? | $498,000 | $611,000 | $446,000 | $2.98M | $366,285 | $1.78M | $1.29M | $1.75M | $2.02M | $1.52M |
| Gross Margin? | +9.4% | +11.3% | +8.4% | +15.8% | +5.1% | +26.6% | +24.8% | +31.5% | +34.9% | +29.7% |
| Operating Expenses? | $5.63M | $6.98M | $7.67M | $7.51M | $7.87M | $4.18M | $3.70M | $3.24M | $2.98M | $2.35M |
| Operating Income? | -$5.14M | -$6.37M | -$7.22M | -$4.53M | -$7.50M | -$2.40M | -$2.41M | -$1.48M | -$954,633 | -$826,952 |
| EBITDA? | -$4.74M | -$5.99M | -$6.87M | -$3.94M | -$7.06M | -$1.93M | -$2.21M | -$1.25M | -$689,340 | -$563,567 |
| Income Before Tax | -$4.97M | -$5.94M | -$7.09M | -$4.51M | -$7.43M | -$2.33M | -$2.37M | -$1.43M | -$908,561 | -$795,987 |
| Income Tax Expense | $1,000 | $42,000 | $51,000 | $23,719 | $13,057 | $7,390 | $24,237 | $31,800 | $0 | $703,800 |
| Net Income? | -$4.97M | -$5.98M | -$7.14M | -$4.53M | -$7.45M | -$2.34M | -$2.39M | -$1.47M | -$908,561 | -$1.50M |
| EPS? | $-2.16 | $-0.36 | $-0.50 | $-0.36 | $-0.54 | $-0.23 | $-0.26 | $-0.17 | $-0.11 | $-0.20 |
| Diluted EPS? | $-2.16 | $-0.36 | $-0.50 | $-0.36 | $-0.54 | $-0.23 | $-0.26 | $-0.17 | $-0.11 | $-0.20 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality